Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.
about
The cost-effectiveness of birth-cohort screening for hepatitis C antibody in U.S. primary care settings.Age cohort differences in illicit drug use and hepatitis C among African American substance usersCost-effectiveness analysis of sofosbuvir compared to current standard treatment in Swiss patients with chronic hepatitis C.New treatments for hepatitis C virus (HCV): scope for preventing liver disease and HCV transmission in EnglandLessons from HIV therapy applied to viral hepatitis therapy: summary of a workshop.Mitochondrial abnormalities in patients with HIV-HCV co-infection as compared to patients with HCV mono-infection.Hepatitis C therapy at home: a hospital and home care partnership.Cost-effectiveness of pegylated interferon and ribavirin for patients with chronic hepatitis C treated in routine clinical practice.Efficacy of combined pegylated interferon and ribavirin therapy in Jewish patients of Israel suffering from chronic hepatitis C.Single centre experience with pegylated interferon and ribavirin for hepatitis C: looking back before moving forward.Assessing uncertainty in the burden of Hepatitis C Virus: comparison of estimated disease burden and treatment costs in the UK.Estimating the likelihood of sustained virological response in chronic hepatitis C therapy.
P2860
Q33834958-519405D8-72FB-4BB4-AA0B-D4F580E02547Q34765207-A6EE10BF-B1D0-4AC4-8F5B-0B332CC4067EQ35606843-21FD1847-A97C-4E65-B284-E3982441E27FQ37169457-021A85D1-33F4-477B-A891-DD510DFD9924Q37678183-AB6D4935-684C-4C64-B7B2-EB4242886743Q43035090-B75FAC47-6A0C-47A3-9E7C-E1BA01144F46Q43406527-6BC7DEF8-2EE7-40D4-83EC-D12001C1932CQ43685787-39F82645-5B11-49C6-8D03-ECBFAD6C8873Q44915630-5CC292C5-0F4E-40F3-98E3-A09E3BF2BB5DQ45836877-AE9E1EA1-16C6-4406-8A9C-DF6DC7E31F4AQ47560957-2E87E63C-5FA0-4BDA-A22B-A9C89A5DA9E6Q50558649-E80B51CB-8EA3-4C03-A803-8105286EE8E9
P2860
Response rates to combination therapy for chronic HCV infection in a clinical setting and derivation of probability tables for individual patient management.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Response rates to combination ...... individual patient management.
@en
type
label
Response rates to combination ...... individual patient management.
@en
prefLabel
Response rates to combination ...... individual patient management.
@en
P2093
P2860
P1476
Response rates to combination ...... individual patient management.
@en
P2093
B J Thomson
D De Angelis
Trent HCV Study Group
W L Irving
P2860
P304
P356
10.1111/J.1365-2893.2007.00941.X
P577
2007-12-11T00:00:00Z